NIT
SGMO

NumerixS Investment Technologies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

NumerixS Investment Technologies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-36,894
Closed -$331K – 697
2020
Q2 		$331K Buy
+36,894
New +$342K 0.09% 261
2020
Q1 		– Sell
-18,700
Closed -$157K – 1241
2019
Q4 		$157K Buy
+18,700
New +$172K 0.03% 562
2018
Q3 		– Sell
-9,000
Closed -$125K – 1350
2018
Q2 		$125K Buy
+9,000
New +$150K 0.03% 681
2018
Q1 		– Sell
-1,300
Closed -$21K – 1255
2017
Q4 		$21K Sell
1,300
-11,027
-89% -$164K ﹤0.01% 995
2017
Q3 		$185K Buy
+12,327
New +$136K 0.04% 536
2015
Q2 		– Sell
-13,900
Closed -$218K – 729
2015
Q1 		$218K Buy
+13,900
New +$215K 0.04% 516

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NumerixS Investment Technologies's SGMO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2020, closing a stake of 36,894 shares — an estimated $331K sold.

NumerixS Investment Technologies first reported a position in SGMO in Q1 2015 and held it in 6 quarters. The position peaked at $331K in Q2 2020. 210 funds tracked by Wall St. Rank hold SGMO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 36,894 SANGAMO THERAPEUTICS INC shares in Q3 2020, an estimated $331K.
  • NumerixS Investment Technologies first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 6 quarters.
  • NumerixS Investment Technologies's SANGAMO THERAPEUTICS INC position peaked at $331K in Q2 2020.
  • 210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.